American society of clinical oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer (vol 21, pg 4042, 2003)

被引：0
|
作者：
Hillner
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 07期
关键词：
D O I：
10.1200/JCO.2004.01.990
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1351 / 1351
页数：1
相关论文
共 50 条
  • [1] American society of clinical oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer
    Hillner, BE
    Ingle, JN
    Chlebowski, RT
    Gralow, J
    Yee, GC
    Janjan, NA
    Cauley, JA
    Blumenstein, BA
    Albain, KS
    Lipton, A
    Brown, S
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (21) : 4042 - 4057
  • [2] American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer
    Hillner, BE
    Ingle, JN
    Berenson, JR
    Janjan, NA
    Albain, KS
    Lipton, A
    Yee, G
    Biermann, JS
    Chlebowski, RT
    Pfister, DG
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1378 - 1391
  • [3] American cancer society guidelines for breast cancer screening: Update 2003
    Smith, RA
    Saslow, D
    Sawyer, KA
    Burke, W
    Costanza, ME
    Evans, WP
    Foster, RS
    Hendrick, E
    Eyre, HJ
    Sener, S
    CA-A CANCER JOURNAL FOR CLINICIANS, 2003, 53 (03) : 141 - 169
  • [4] Barriers to clinical trial participation by older women with breast cancer (vol 21, pg 2268, 2003)
    Kemeny
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) : 4863 - 4863
  • [5] American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer (vol 29, pg 1221, 2011)
    Van Poznak, C. H.
    Temin, S.
    Yee, G. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (16) : 2293 - 2293
  • [6] American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma
    Kyle, Robert A.
    Yee, Gary C.
    Somerfield, Mark R.
    Flynn, Patrick J.
    Halabi, Susan
    Jagannath, Sundar
    Orlowski, Robert Z.
    Roodman, David G.
    Twilde, Patricia
    Anderson, Kenneth
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (17) : 2464 - 2472
  • [7] American Society of Clinical Oncology Clinical Practice Guideline Update: Recommendations on the Role of Bone-Modifying Agents in Metastatic Breast Cancer
    Van Poznak, Catherine H.
    Von Roenn, Jamie H.
    Temin, Sarah
    JOURNAL OF ONCOLOGY PRACTICE, 2011, 7 (02) : 117 - 121
  • [8] American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003
    Pfister, DG
    Johnson, DH
    Azzoli, CG
    Sause, W
    Smith, TJ
    Baker, S
    Olak, J
    Stover, D
    Strawn, JR
    Turrisi, AT
    Somerfield, MR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) : 330 - 353
  • [9] American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer
    Van Poznak, Catherine H.
    Temin, Sarah
    Yee, Gary C.
    Janjan, Nora A.
    Barlow, William E.
    Biermann, J. Sybil
    Bosserman, Linda D.
    Geoghegan, Cindy
    Hillner, Bruce E.
    Theriault, Richard L.
    Zuckerman, Dan S.
    Von Roenn, Jamie H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) : 1221 - 1227
  • [10] Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer (vol 327, pg 469, 2003)
    Ross, JR
    BRITISH MEDICAL JOURNAL, 2004, 328 (7436): : 384 - 384
12345